---
$id: https://graph.org.ai/products/commodity/51131814
$type: Product
source: UNSPSC
code: "51131814"
title: "Aprotinin"
class: "51131800"
classTitle: "Coagulants and systemic hemostatic agents"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Aprotinin

**UNSPSC Code**: 51131814
**Class**: [Coagulants and systemic hemostatic agents](Coagulants and systemic hemostatic agents.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protease inhibitor with the molecular formula C284H432N84O79S7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 04XPW8C0FL. European Medicines Agency schedules aprotinin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05546MIG. The term APROTININ is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24. ). APROTININ is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aprotinin under HS 29349990 and SITC 51579. As of Q4 2014, APROTININ remains the US FDA Preferred Term for this commodity. Aprotinin bears US NLM identifiers UMLS ID C0003641 and NCI Concept Code C47402. SMILES: S1SCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C3NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=.

